SACK1A and neoplasm: Targeting FAM83A expression in the KP-Cre cells using shRNA against murine FAM83A (shA4) significantly reduced in vitro cell growth (Fig. 7e), anchorage-independent growth in soft agar (Fig. 7f) and in vivo tumour formation (Fig. 7g).